Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

被引:19
|
作者
Stavropoulos, Konstantinos [1 ]
Imprialos, Konstantinos [1 ]
Pittaras, Andreas [2 ,3 ]
Faselis, Charles [2 ,3 ]
Narayan, Puneet [2 ,3 ]
Kokkinos, Peter [2 ,3 ]
机构
[1] Aristotle Univ Thessaloniki, Propaedeut Dept Med 2, Thessaloniki, Greece
[2] VAMC, Washington, DC USA
[3] Georgetown Univ, Sch Med, Washington, DC 20057 USA
关键词
Non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; lifestyle modification; weight loss; physical activity; nutrition; diet; CORONARY-HEART-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; BODY-MASS INDEX; PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; EXERCISE CAPACITY; WEIGHT-LOSS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; RISK-FACTORS;
D O I
10.2174/1570161115666170621080835
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is one of the most common diseases worldwide, affecting more than 30% of general population. High-fat diets, physical inactivity and obesity, all prevalent in the western societies, are strongly associated with the development and progression of NAFLD. Current drug therapies have not consistently shown substantial beneficial effects. Thus, lifestyle modification appears to be the optimal intervention in combating the disease. Accordingly, several studies have concluded that weight loss, via increase in physical activity, and dietary interventions could potential ameliorate biochemical, histological, and structural abnormalities of non-alcoholic fatty liver disease. The aim of this review is to summarize the findings of these lifestyle intervention studies and discuss the implementation of each intervention, and its effectiveness in the management of the disease in everyday clinical practice.
引用
收藏
页码:239 / 245
页数:7
相关论文
共 50 条
  • [21] Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essential
    Bedossa, Pierre
    [J]. LIVER INTERNATIONAL, 2018, 38 : 64 - 66
  • [22] Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Tincopa, Monica A.
    Loomba, Rohit
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (07): : 660 - 670
  • [23] Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Ahsan, Farah
    Oliveri, Federico
    Goud, Harshit K.
    Mehkari, Zainab
    Mohammed, Lubna
    Javed, Moiz
    Althwanay, Aldanah
    Rutkofsky, Ian H.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [24] The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Zhang, Chunye
    Liu, Shuai
    Yang, Ming
    [J]. GASTROENTEROLOGY INSIGHTS, 2022, 13 (02) : 148 - 161
  • [25] Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis
    Angelico, F.
    Burattin, M.
    Alessandri, C.
    Del Ben, M.
    Lirussi, F.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [26] What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis?
    Doumas, Michael
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Athyros, Vasilios G.
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (05) : 425 - 428
  • [27] The importance of regular screening for HCC in non-alcoholic steatohepatitis/non-alcoholic fatty liver disease
    Keitoku, Taisei
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Uchihara, Naoki
    Suzuki, Keito
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Ishido, Shun
    Matsumoto, Hiroaki
    Nobusawa, Tsubasa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Takahashi, Yuka
    Tsuchiya, Kaoru
    Huang, Hiroyuki Nakanishi Daniel
    Izumi., Namiki
    Red, Musashino
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S644 - S644
  • [28] Ultrasonographic index for the diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease
    Kim, Jeong Woo
    Lee, Chang Hee
    Kim, Baek-Hui
    Lee, Young-Sun
    Hwang, Soon-Young
    Park, Bit Na
    Park, Yang Shin
    [J]. QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2022, 12 (03) : 1815 - 1829
  • [30] Recent News on Statins for the Treatment of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis
    Athyros, Vasilios G.
    Katsiki, Niki
    Doumas, Michael
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (02) : 104 - 106